GeneBioTech Co Ltd (086060)

KOSDAQ

Currency in KRW

4,255

-25(-0.58%)

Closed·11:59:59

Fair Value

Unlock Value

Day's Range

4,180

4,290

52 wk Range

3,015

4,790

086060 Income Statement

Featured here, the Income Statement (earnings report) for GeneBioTech Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

59,119.19

62,813.56

82,758.51

79,476.92

82,959.22

Total Revenues Growth

aa.aa

+1.5%

+6.25%

+31.75%

-3.97%

+4.38%

Cost of Revenue

aa.aa

49,684.65

55,374.12

72,409.19

65,824.97

69,589.46

Gross Profit

aa.aa

9,434.54

7,439.44

10,349.32

13,651.94

13,369.76

Gross Profit Growth

aa.aa

-1.13%

-21.15%

+39.11%

+31.91%

-2.07%

Gross Profit Margin %

aa.aa

15.96%

11.84%

12.51%

17.18%

16.12%

Other Operating Expenses, Total

aa.aa

10,531.35

7,892.59

8,792.44

9,679.17

9,526.17

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+21.04%	-25.06%	+11.4%	+10.09%	-1.58%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,032.79	820.81	765.04	837.22	875.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9,236.89	6,748.94	7,646.81	8,426.69	8,189.16
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	99.16	106.95	108.26	104.84	102.78

Operating Income

aa.aa

-1,096.82

-453.15

1,556.88

3,972.78

3,843.59

Operating Income Growth

aa.aa

-230.36%

+58.69%

+443.57%

+155.18%

-3.25%

EBIT Margin %

aa.aa

-1.86%

-0.72%

1.88%

4.63%

Net Interest Expenses

aa.aa

-24.75

-12.53

88.18

157.6

Net Interest Expenses Growth

aa.aa

+49.36%

+803.58%

+78.73%

Interest Expense, Total

aa.aa

-152

-276.45

-581.38

-642.98

Interest And Investment Income

aa.aa

127.25

263.92

669.56

800.59

Other Non Operating Expenses, Total

aa.aa

663.14

-353.14

270.35

-118.01

-620.92

EBT, Excl. Unusual Items

aa.aa

-433.68

-831.03

1,814.7

3,942.95

3,380.28

Gain (Loss) On Sale Of Assets

aa.aa

13.85

-5.88

-0

20.69

122.26

Other Unusual Items, Total

aa.aa

-0.85

-589.54

EBT, Incl. Unusual Items

aa.aa

-419.83

-837.76

1,814.7

3,374.09

3,502.54

EBT, Incl. Unusual Items Growth

aa.aa

-219.93%

-99.54%

+316.61%

+85.93%

+3.81%

EBT, Incl. Unusual Items Margin

aa.aa

-0.71%

-1.33%

2.19%

4.25%

4.22%

Income Tax Expense

aa.aa

-358.37

-353.36

291.39

782.7

637.3

Net Income to Company

aa.aa

-3,431.53

-484.4

1,523.31

2,591.4

2,865.23

Minority Interest

aa.aa

1,090.22

Net Income

aa.aa

-2,341.31

-484.4

1,523.31

2,591.4

2,865.23

Net Income Growth

aa.aa

-376.5%

+79.31%

+414.47%

+70.12%

+10.57%

Net Income Margin %

aa.aa

-3.96%

-0.77%

1.84%

3.26%

3.45%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,028.75

-484.4

1,523.31

2,591.4

2,865.23

Basic EPS - Continuing Operations

aa.aa

119.47

-56.26

176.91

300.95

332.76

Basic EPS - Continuing Operations Growth

aa.aa

+21.49%

-147.09%

+414.47%

+70.12%

+10.57%

Diluted EPS - Continuing Operations

aa.aa

119.47

-56.26

176.91

300.95

332.76

Diluted EPS - Continuing Operations Growth

aa.aa

+21.49%

-147.09%

+414.47%

+70.12%

+10.57%

Basic Weighted Average Shares Outstanding

aa.aa

8.61

Diluted Weighted Average Shares Outstanding

aa.aa

8.61

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

950.17

791.25

2,843.25

5,311.24

5,211.98

EBITDA Growth

aa.aa

-62.39%

-16.73%

+259.34%

+86.8%

-1.87%

EBITDA Margin %

aa.aa

1.61%

1.26%

3.44%

6.68%

6.28%

EBIT

aa.aa

-1,096.82

-453.15

1,556.88

3,972.78

3,843.59

* In Millions of KRW (except for per share items)

Nifty 50

24,971.90

-140.50

-0.56%

BSE Sensex

81,896.79

-511.38

-0.62%

Nifty Bank

56,059.35

-193.50

-0.34%

Nifty 50 Futures

24,993.00

-118.70

-0.47%

US 500

5,980.00

+12.2

+0.20%

FTSE 100

8,762.25

-12.40

-0.14%

Dollar Index

98.257

-0.025

-0.03%

Market Movers

Name	Last	Chg. %	Vol.
Zee Entertainment	149.66	+12.46%	163.87M
Bharat Electronics	420.90	+3.10%	43.02M
BSE	2,775.30	+3.24%	7.00M
Garden Reach	3,492.70	+6.24%	4.93M
BEML	4,788.70	+3.22%	3.01M
Trent	6,120.00	+3.77%	2.27M
Dixon Tech	14,554.10	+3.55%	1.74M

Name	Last	Chg. %	Vol.
Lakshmi Mills	8,635.85	+20.00%	2.90K
Tamilnadu Telecomm	11.760	+20.00%	472.45K
Ishan Dyes and Chemicals	53.49	+19.99%	68.35K
Kerala Ayurveda	511.70	+19.99%	2.93M
Parmax Pharma	38.02	+19.97%	22.24K
Silver Pearl Hospitality Luxury	10.58	+19.95%	40.00K
Tamilnadu Telecomm	11.92	+19.92%	129.05K

Name	Last	Chg. %	Vol.
City Crops Agro	22.16	-11.36%	300.00K
Beeyu Overseas	3.280	-11.11%	1.69K
Vani Commercials	10.90	-10.21%	121.30K
Osia Hyper	18.00	-10.04%	1.43M
Naapbooks	126.85	-9.97%	1.20K
Continental Controls	8.78	-9.95%	36.00
United Interactive	98.20	-9.88%	1.69K

Trending Stocks

Name	Last	Chg. %	Vol.
Bharat Electronics	420.90	+3.10%	43.02M
HDFC Bank	1,948.40	-0.83%	5.87M
Zee Entertainment	149.66	+12.46%	163.87M
Reliance Industries	1,456.80	-0.64%	5.99M
BSE	2,775.30	+3.24%	7.00M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaa Aa	195.75	+44.77%	283.39
Aaaaaa Aaaaaaaa	62.87	+41.66%	89.06
Aa Aaaaa Aaaaaa	111.65	+38.59%	154.74
Aaa Aaaa Aaaaaaaaaa	549.30	+38.25%	759.41
A A Aaa Aaaaaaa	867.95	+38.06%	1,198.29
Aaaa Aaaa Aaaaaaa	869.20	+38.04%	1,199.84
Aaaaa Aaa	231.00	+37.94%	318.64

Name	Last	Upside	Fair Value
Aaaaaaaaa Aa	195.75	+44.77%	283.39
Aaaaaa Aaaaaaaa	62.87	+41.66%	89.06
Aa Aaaaa Aaaaaa	111.65	+38.59%	154.74
Aaa Aaaa Aaaaaaaaaa	549.30	+38.25%	759.41
A A Aaa Aaaaaaa	867.95	+38.06%	1,198.29
Aaaa Aaaa Aaaaaaa	869.20	+38.04%	1,199.84
Aaaaa Aaa	231.00	+37.94%	318.64

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

GeneBioTech Co Ltd (086060)

086060 Income Statement

Trending Stocks